Search

everythinglearnresearchcommunity

for

Search:↓

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Sex hormone supplements help improve breathing and nerve recovery after spinal injury in rats.

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Topical finasteride may help treat facial hirsutism in women.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Lowering testosterone speeds up wound healing in male mice.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in certain receptors can cause diseases and offer new treatment options.

AR gene not major factor in female hair loss; different from male hair loss.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Estrogen is important for keeping adult mouse nipple skin healthy by controlling certain cell signals.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Longer CAG repeats in gene linked to more severe hair loss in females.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Estrogen increases a growth factor in hair cells which might affect hair loss.

New compounds with carborane showed anti-androgen effects similar to flutamide.